SAPHO Part 2: An Abundance of Acronyms (AAOA)

What does the PAPA spectrum disorder teach us about SAPHO? Is SAPHO an autoinflammatory condition or part of the SpA spectrum? Why have antibiotics been used to treat this condition? Find out in this episode!

Brought to you by Tremfya.

Intro :01
Welcome to another exciting episode of Rheuminations :11
About today's episode :17
A summary of SAPHO Part 1 :24
What to expect in this episode 1:28
Earlier long-term data 2:27
A more recent paper from Italy 6:47
Therapeutics in detail 12:17
Summary so far 21:39
IL-1 inhibition in SAPHO 22:32
Monogenic pediatric conditions 33:58
Why can't we check the genes in SAPHO? 40:00
Episode summary 41:55
We went through a lot in this paper 45:29
Thanks for listening 43:53

Disclosure: Brown reports no relevant financial disclosures.

We'd love to hear from you! Send your comments/questions to Dr. Brown at [email protected]. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum and be sure to check out Rheum + Boards – your destination for rheumatology education and quizzes!

References:

Agak GW, et al. J Invest Dermatol. 2014;134:366-373.

Aksentijevich I, et al. N Engl J Med. 2009;360:2426-2437.

Assmann G, Simon P. Best Pract Res Clin Rheumatol. 2011;25:423-434.

Boursier G, et al. J Invest Dermatol. 2021;141:1141-1147.

Cai R, et al. Front Cell Dev Biol. 2021;doi:10.3389/fcell.2021.643644.

Colina M, et al. Arthritis Rheum. 2009;61:813-821.

Daoussis D, et al. Semin Arthritis Rheum. 2019;48:618-625.

Eun IS, et al. J Clin Neurosci. 2021;92:153-158.

Ferguson PJ, El-Shanti H. Biomolecules. 2021;11:367.

Grosse J, et al. Blood. 2006;107:3350-3358.

Guignard S, et al. Joint Bone Spine. 2002;69:392-396.